Vote
Vote
Vote
Vote
Vote
Vote
Vote
Vote
Vote
Vote
Vote
Vote
Vote
Vote
Vote

Esconder

Guia 2021

Cadastre-se
anuncie
MENU

Cotação de Ingredientes

Guia de Fornecedores

CADASTRE SUA EMPRESA - CLIQUE AQUI


Rousselot and Pharmatec produce fortifed gummies using SiMoGel

Rousselot and Norwegian medicine manufacturer Pharmatech have successfully created a range of gelatin-based fortified gummies using Rousselot’s SiMoGel solution.

A statement from Rousselot claims that Pharmatech is the first Europe-based company to successfully produce gelatin-based nutraceutical gummies thanks to the SiMoGel ingredient.

SiMoGel was developed by Rousselot in 2018, and the solution enables the production of fortified gummies in a starch-free environment, eliminating the risk of cross-contamination associated with production in starch moulds.

The two teams worked closely on-site from the qualification process throughout all industrial trials to develop a specific sugar-free recipe, to optimise the production process and lower the production costs.

The flexible production process will also allow Pharmatech to tailor a batch size to the needs of customers, starting from 500 kg, the equivalent of around 75,000 and 250,000 gummies.

Jeff Daelman, product & BD manager at Rousselot, said: “The partnership between Pharmatech and Rousselot goes back a long way and we were delighted to support them in this pioneering project with SiMoGel, especially since they already had the necessary equipment for molding the gummies.

“It was a pleasure to see Pharmatech operators produce high-quality, fortified gummies within a few hours.”

Geir Andreas Lund, business manager at Pharmatech, added: “SiMoGel was proposed to us in early 2018.

“Pharmatech was looking for a stable gelatin-based formulation, starch free and easy to produce and SiMoGel sounded perfect for our innovation projects.

“By using SiMoGel we now have the ability to produce more complex formulations with ingredients that are not suitable for standard gelatin qualities.”

“The fact that SiMoGel is also available in a bovine version is an added benefit which opens up a larger market.

“Rousselot made the formulation process extremely smooth by providing us with SiMoGel samples and assisting on-site during the trials.

“Thanks to the combined effort of both our teams and the good technical advice from Rousselot, the end result was very much satisfactory!”




Notícias relacionadas



Envie uma notícia



Telefones:

Comercial:

11 99834-5079

Newsletter:

© EDITORA INSUMOS LTDA.

001